M

Medican Enterprises Inc
OTC:MDCN

Watchlist Manager
Medican Enterprises Inc
OTC:MDCN
Watchlist
Price: 0.0001 USD
Market Cap: $28.8k

Net Margin

0%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Net
Margin
US
Medican Enterprises Inc
OTC:MDCN
28.8k USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
975.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
549.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.2B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.3B EUR
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Medican Enterprises Inc
Glance View

Market Cap
28.8k USD
Industry
Pharmaceuticals

Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the production, cultivation, and wholesale distribution of cannabis related products. The company is headquartered in Las Vegas, Nevada and currently employs 3 full-time employees. The company went IPO on 2000-05-22. The firm is engaged in wholesale medical marijuana production, cultivation, and wholesale distribution of cannabis related products. Through joint ventures with development partners all over Canada and the United States, the Company builds and operates medical marijuana cultivation and research centers. The firm focuses on cultivating approximately five strains of cannabis, including High tetrahydrocannabinol (THC)/Low Cannabidiol (CBD), Medium THC/Low CBD, Medium THC/Medium CBD and Low TCH/High CBD. The firm provides strategic planning, valuation, project debt and corporate finance solutions to its joint venture partners in order to capitalize on the growing medical marijuana market and fund multiple facilities. The firm's subsidiary, Medican Systems Inc., is a licensed producer of medical marijuana under the new program marijuana for medical purposes regulation.

MDCN Intrinsic Value
Not Available
M
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Back to Top